<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03247842</url>
  </required_header>
  <id_info>
    <org_study_id>3024/01/15</org_study_id>
    <nct_id>NCT03247842</nct_id>
  </id_info>
  <brief_title>The Analgesic Efficacy Supra-scapular Nerve RF After Breast Surgery</brief_title>
  <official_title>The Analgesic and Rehabilitative Value of Supra-scapular Nerve Radiofrequency in Patients With Chronic Shoulder Pain After Breast Surgery.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Tanta University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Tanta University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Eighty patients with chronic shoulder pain after breast surgery were allocated randomly into
      2 groups; forty patients received fluoroscopically guided supra-scapular nerve pulsed
      radiofrequency (PRF) followed by injection of 0.25% bupivacaine solution containing 40 mg of
      methylprednisolone (group1) and forty patients received fluoroscopically guided
      supra-scapular nerve injection of of 0.25% bupivacaine solution containing 40 mg of
      methylprednisolone (group 2) without active pulsed radiofrequency only demo mode was applied.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Eighty patients with chronic shoulder pain after breast surgery were allocated randomly into
      2 groups ; forty patients received fluoroscopically guided supra-scapular nerve pulsed
      radiofrequency (PRF) followed by injection through the radiofrequency needle of 0.25%
      bupivacaine solution containing 40 mg of methylprednisolone (group1) and forty patients
      received fluoroscopically guided supra-scapular nerve injection of 0.25% bupivacaine solution
      containing 40 mg of methylprednisolone (group 2) without active pulsed radiofrequency only
      demo mode was applied.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">April 25, 2017</start_date>
  <completion_date type="Actual">June 30, 2019</completion_date>
  <primary_completion_date type="Actual">September 30, 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>postoperative pain</measure>
    <time_frame>immedite postopertive</time_frame>
    <description>assessment using visual analogue scale</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>shoulder movement</measure>
    <time_frame>6 months after surgery</time_frame>
    <description>shoulder mobility using long arm geniometry</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">80</enrollment>
  <condition>Chronic Pain Syndrome</condition>
  <arm_group>
    <arm_group_label>suprascapular nerve RF</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Eighty patients with chronic shoulder pain after breast surgery were allocated randomly into 2 groups (Figure1); forty patients received fluoroscopically guided supra-scapular nerve pulsed radiofrequency (PRF) followed by injection through the radiofrequency needle of mL of 0.25% bupivacaine solution containing 40 mg of methylprednisolone (group1)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>suprascapular nerve block</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>and forty patients received fluoroscopically guided supra-scapular nerve injection of mL of 0.25% bupivacaine solution containing 40 mg of methylprednisolone (group 2) without active pulsed radiofrequency only demo mode was applied.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>suprascapular nerve block</intervention_name>
    <description>Sixty patients with shoulder dystocia after breast surgery will receive stellate ganglion neurolysis with supra-scapular nerve radiofrequency,</description>
    <arm_group_label>suprascapular nerve RF</arm_group_label>
    <arm_group_label>suprascapular nerve block</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients with post-mastectomy pain

        Exclusion Criteria:

          -  Exclusion criteria are patients with any medical contraindications to neurolysis,
             patients with other bone metastases.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <gender_description>patients with cancer breast</gender_description>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Tanta university hospital</name>
      <address>
        <city>Cairo</city>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>June 2020</verification_date>
  <study_first_submitted>April 24, 2017</study_first_submitted>
  <study_first_submitted_qc>August 8, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">August 14, 2017</study_first_posted>
  <last_update_submitted>June 12, 2020</last_update_submitted>
  <last_update_submitted_qc>June 12, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">June 16, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Tanta University</investigator_affiliation>
    <investigator_full_name>Ayman Abd Al-maksoud Yousef</investigator_full_name>
    <investigator_title>assistant professor</investigator_title>
  </responsible_party>
  <keyword>post mastectomy pain</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Chronic Pain</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

